Biocompare.com News Feeds Biocompare.com RSS feed http://www.biocompare.com/ © 2010 Biocompare.com Sun, 01 Aug 2010 02:43:22 GMT http://backend.userland.com/rss RSS.NET: http://www.rssdotnet.com/ Abbott Laboratories (ABT)'s SIMCOR(R) (Niacin Extended-Release/Simvastatin ) Receives FDA Approval For New Dosage Strengths Abbott (NYSE:ABT - News) today received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCORŽ, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott's proprietary niacin extended-release and simvastatin, the most commonly used statin. http://news.biocompare.com/newsstory.asp?id=335996 Biocompare.com Fri, 30 Jul 2010 15:21:00 GMT UPDATE 2-U.S. FDA Warns Of Pneumonia Risk With Cubist Drug U.S. health officials warned Thursday about the risk of pneumonia with Cubist Pharmaceuticals Inc's (CBST.O) flagship antibiotic. http://news.biocompare.com/newsstory.asp?id=335995 Biocompare.com Fri, 30 Jul 2010 15:19:00 GMT Clinical Laboratory Tests As A Commodity: Why Government Health Programs Won't Spend More Too often, pathology laboratory testing is treated as a commodity by government health officials in the United States and other countries. But treating lab testing as a commodity has negative long-term consequences for health systems which try to pay the cheapest price for medical laboratory testing. http://news.biocompare.com/newsstory.asp?id=335993 Biocompare.com Fri, 30 Jul 2010 15:15:00 GMT Study Links Glaucoma Medication Use And Presence, Severity Of Ocular Surface Disease Patients undergoing medical treatment for glaucoma experienced a high rate of ocular surface disease, a study showed. http://news.biocompare.com/newsstory.asp?id=335994 Biocompare.com Fri, 30 Jul 2010 15:15:00 GMT FDA Finds Pneumonia Risk With Daptomycin The FDA said that the intravenous antibiotic daptomycin (Cubicin) may be linked to an increased risk of eosinophilic pneumonia -- a rare but serious potential side effect -- and requested that a new drug label warning be added. http://news.biocompare.com/newsstory.asp?id=335992 Biocompare.com Fri, 30 Jul 2010 15:14:00 GMT Fever Often Missing In Mild Pandemic Flu Physicians using standard diagnostic criteria may miss mild cases of the pandemic flu, researchers reported. http://news.biocompare.com/newsstory.asp?id=335990 Biocompare.com Fri, 30 Jul 2010 15:13:00 GMT Estradiol Spray May Pose Risk For Kids And Pets Menopausal women who use a spray form of topical estradiol (Evamist) to control hot flushes should avoid touching children and pets with treated areas of the skin, the FDA warned. http://news.biocompare.com/newsstory.asp?id=335991 Biocompare.com Fri, 30 Jul 2010 15:13:00 GMT Court Ruling Could Pave Way For Gemzar Generics A decision by a U.S. appeals court could pave the way for cheaper generic forms of Eli Lilly and Co's Gemzar cancer drug to be launched in the United States beginning in mid-November. http://news.biocompare.com/newsstory.asp?id=335989 Biocompare.com Fri, 30 Jul 2010 15:12:00 GMT Obese Patients Lose Weight On New Orexigen Drug Overweight volunteers who took Orexigen's experimental drug Contrave, designed to reduce cravings, lost about 13 pounds (6 kg) over a year, U.S. researchers reported on Thursday. http://news.biocompare.com/newsstory.asp?id=335987 Biocompare.com Fri, 30 Jul 2010 15:11:00 GMT New TB Test Must Reach More People: Expert A new diagnostic tool that reduces to two hours the time needed to detect drug-resistant tuberculosis must be made available to populations vulnerable to the disease, a World Health Organization expert said. http://news.biocompare.com/newsstory.asp?id=335988 Biocompare.com Fri, 30 Jul 2010 15:11:00 GMT